The Re-election of Directors at 2016 Annual General Shareholders’ Meeting

OBI Pharma ‘s 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction
June 27, 2016
Important resolutions of 2016 Annual General Shareholders’ Meeting
June 27, 2016

1.Date of occurrence of the change:2016/06/27
2.Appointment of or changed personnel (juristic-person director, juristic-person supervisor, independent director, natural-person director or natural-person supervisor):natural-person director, juristic-person director, independent director.
3.Title, name and resume of the replaced personnel:
Director: Michael Chang, Chairman of OBI Pharma, Inc.
Director: Youe-Kong Shue, Director of OBI Pharma, Inc.
Director: Tamon Tseng, Representative of Hui Hong Investment Management Co., Limited/Special Assistant to the CEO of Ruentex Industries, Ltd.
Director: Lung-Yeh Cho, Representative of Hui Hong Investment Management Co., Limited/ Special Assistant to the CEO of Hui Hong Investment Management Co., Limited
Director: Howard Lee, Representative of Alpha Corporate Holdings Limited/ Director of OBI Pharma, Inc.
Independent Director: Yang-tzong Tsay/ Professor and Chairman of Accounting at the National Taiwan University College of Management.
Independent Director: Jerry G. Fong/ Director of Graduate Institute of Intellectual Property (IIP) at NCCU
Independent Director: Chung-Ming Chang/ Dean of Academic Affairs of National Yang-Ming University, Director of Microbiology and Immunology Graduate Institute.
4.Title, name and resume of the new personnel:
Director: Michael Chang, Representative of Yi Tai Fund Co./ Chairman of OBI Pharma, Inc.
Director: Tamon Tseng, Representative of Yi Tai Fund Co./Special Assistant to the CEO of Ruentex Industries, Ltd.
Director: Lung-Yeh Cho, Representative of Sun Cheng Fund Co./ Special Assistant to the CEO of Ruentex Group.
Director: Frank Chen, Representative of Sun Cheng Fund Co./ Vice President, Investment Management, Ruentex Group
Independent Director: Jerry G. Fong, Director of Graduate Institute of Intellectual Property (IIP) at NCCU
Independent Director: Chung-Ming Chang, Dean of Academic Affairs of National Yang-Ming University, Director of Microbiology and Immunology Graduate Institute,
Independent Director: Tay-Chang Wang, Professor of Accounting at the National Taiwan University College of Management.
5.Type of the change (please enter: “resignation”, “discharge”, “tenure expired”, “death” or “new appointment” ):tenure expired
6.Reason for the change:Re-election
7.Number of shares held by the new personnel at the time of appointment:
Director: Michael Chang, Representative of Yi Tai Fund Co./ 25,765,032 shares
Director: Tamon Tseng, Representative of Yi Tai Fund Co. / 25,765,032 shares
Director: Lung-Yeh Cho, Representative of Sun Cheng Fund Co./ 250,000 shares
Director: Frank Chen, Representative of Sun Cheng Fund Co./ 250,000 shares
Independent Director: Jerry G. Fong/0 shares
Independent Director: Chung-Ming Chang /0 shares
Independent Director: Tay-Chang Wang /0 shares
8.Original term (from __________ to __________):2013/02/07~2016/02/06
9.Effective date of the new appointment:2016/06/27
10.Rate of turnover of directors of the same term: N/A
11.Rate of turnover of supervisor of the same term: N/A
12.Rate of turnover of independent director of the same term: N/A
13.Change in one-third or more of directors (“Yes” or “No”): No
14.Any other matters that need to be specified: None.